3684-12-6

Basic information

• Product Name: ANILINO(PHENYL)ACETIC ACID
• Synonyms: PHENYL-PHENYLAMINO-ACETIC ACID;alpha-(phenylamino)-benzeneaceticaci;n,2-diphenyl-glycin;n,2-diphenylglycine;CHEMBRDG-BB 4140263;ANILINO(PHENYL)ACETIC ACID;2-Anilino-2-phenylacetic acid;anilino(phenyl)acetic acid(SALTDATA: FREE)
• CAS NO: 3684-12-6
• Molecular Formula: C₁₄H₁₃NO₂
• Molecular Weight: 227.26
• Mol File: 3684-12-6.mol

Chemical Properties

• Boiling Point: 412.3 °C at 760 mmHg
• Flash Point: 203.2 °C
• Appearance: /
• Density: 1.252 g/cm³
• Vapor Pressure: 1.54E-07mmHg at 25°C
• CAS DataBase Reference: ANILINO(PHENYL)ACETIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: ANILINO(PHENYL)ACETIC ACID(3684-12-6)
• EPA Substance Registry System: ANILINO(PHENYL)ACETIC ACID(3684-12-6)

Safety Data

• Hazard Codes: C
• Hazardous Substances Data: 3684-12-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
ANILINO(PHENYL)ACETIC ACID is used as a key intermediate in the synthesis of pharmaceutical compounds due to its versatile chemical properties and potential therapeutic effects.
Used in Pain Management:
ANILINO(PHENYL)ACETIC ACID is used as an analgesic agent for its pain-relieving properties, offering a potential solution for managing various types of pain.
Used in Anti-Inflammatory Treatments:
Leveraging its anti-inflammatory characteristics, ANILINO(PHENYL)ACETIC ACID is utilized in the development of treatments aimed at reducing inflammation and associated discomfort.
Used in Antipyretic Formulations:
Capitalizing on its antipyretic properties, ANILINO(PHENYL)ACETIC ACID is employed in the creation of medications designed to reduce fever.
Used in Chronic Pain and Inflammatory Condition Treatments:
ANILINO(PHENYL)ACETIC ACID is explored for its potential application in treating chronic pain and inflammatory conditions, offering hope for more effective therapeutic interventions in these areas.
Proper handling and storage are crucial for the safe use of ANILINO(PHENYL)ACETIC ACID in both laboratory and industrial settings, ensuring that its benefits can be harnessed while minimizing any risks associated with its chemical nature.

InChI:InChI=1/C14H13NO2/c16-14(17)13(11-7-3-1-4-8-11)15-12-9-5-2-6-10-12/h1-10,13,15H,(H,16,17)/p-1/t13-/m1/s1

Upstream product

• 60561-61-7 α-anilino-α-phenylacetamide 
• 4870-65-9 2-bromophenylacetic acid 
• 62-53-3 aniline 
• 4755-72-0 Chloro-phenyl-acetic acid 
• 124-38-9 carbon dioxide 
• 538-51-2 benzylidene phenylamine 
• 123-51-3 i-Amyl alcohol 
• 39881-21-5 1,3,4,6-tetraphenyl-piperazine-2,5-dione 
• 4553-59-7 2-anilino-2-phenylacetonitrile 
• 2935-35-5 (S)-2-phenylglycine 
• 108-90-7 chlorobenzene 
• 60686-79-5 (R)-2-bromo-2-phenylacetic acid 
• 100-52-7 benzaldehyde 
• 127-17-3 2-oxo-propionic acid 

Downstream Products

• 52827-05-1 DL-2-(N-Nitrosoanilino)-2-phenylessigsaeure 
• 57750-04-6 3,4-diphenyl-2,2-bis-trifluoromethyl-oxazolidin-5-one 
• 13328-72-8 2-methyl-2,3,4-triphenyl-[1,3,2]oxazasilolidin-5-one 
• 61831-63-8 2-phenyl-3-n-propylquinoline 
• 5278-43-3 3-methyl-2-phenyl-quinoline 
• 4789-73-5 2-phenyl-6-methoxyquinoline 
• 612-96-4 2-Phenylquinoline 
• 27356-66-7 4-methoxy-2-phenyl-1,2,3,4-tetrahydro-quinoline 
• 1026-05-7 2-methyl-1,2,3,4-tetrahydroquinolin-4-yl-(phenyl)amine 
• 1352633-39-6 (R)-1-(2-(5-ethylthiophen-3-yl)-2-oxoethyl)-3-((R)-2-phenyl-2-(phenylamino)acetoxy)-1-azoniabicyclo[2.2.2]octane 2,2,2-trifluoroacetate 
• 1352633-36-3 (R)-1-(2-(3-aminophenyl)-2-oxoethyl)-3-((R)-2-phenyl-2-(phenylamino)acetoxy)-1-azoniabicyclo[2.2.2]octane 2,2,2-trifluoroacetate 
• 1352633-34-1 (R)-1-(2-(4-carboxyphenyl)-2-oxoethyl)-3-((R)-2-phenyl-2-(phenylamino)acetoxy)-1-azoniabicyclo[2.2.2]octane 2,2,2-trifluoroacetate 
• 1352633-32-9 (R)-1-(2-(3-cyanophenyl)-2-oxoethyl)-3-((R)-2-phenyl-2-(phenylamino)acetoxy)-1-azoniabicyclo[2.2.2]octane bromide 

Relevant articles and documents

Integrated Flow Synthesis of α-Amino Acids byIn SituGeneration of Aldimines and Subsequent Electrochemical Carboxylation

The synthesis of α-amino acids was carried out in a continuous flow system. In this system, aldimines were efficiently generatedin situvia the dehydration-condensation of aldehydes with anilines in a desiccant bed column filled with 4 ? molecular sieves d

FULLERENE DERIVATIVE AND n-TYPE SEMICONDUCTOR MATERIAL

An object of the present invention is to provide a novel fullerene derivative usable in n-type semiconductor materials for organic thin-film solar cells and the like. The object is achieved by a fullerene derivative represented by formula (1) wherein Rs

A synthesis of α-amino acids via direct reductive carboxylation of imines with carbon dioxide

A method for the synthesis of α-amino acids by direct reductive carboxylation of aromatic imines with CO2 is described. The protocol employs readily available commercial reagents and serves as a one-step alternative to the Strecker synthesis. The Royal Society of Chemistry 2013.

Nanoparticle catalyzed reaction (NPCR): ZnO-NP catalyzed Ugi-reaction in aqueous medium

The first ZnO-NP catalyzed Ugi type three-component (AB2C) reaction has been developed for the synthesis of 2-arylamino-2- phenylacetimidamide from an aldehyde, amine and isocyanide in aqueous media. This nanoparticle catalysed reaction (NPCR)

Boric acid catalyzed Ugi three-component reaction in aqueous media

B(OH)3 catalyzed Ugi three-component reaction for the synthesis of 2-arylamino-2-phenylacetamide has been developed using aldehydes, amines, and isocyanides in water. The synthesized 2-arylamino-2-phenylacetamides were efficiently converted int

ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF

The present invention relates to alkaloid aminoester compounds which act as muscarinic receptor antagonists, processes for their preparation, compositions comprising them, and therapeutic uses thereof.

ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF

The present invention relates to alkaloid aminoester compounds which act as muscarinic receptor antagonists, processes for the preparation of such a compound, compositions which contain such a compound, and therapeutic uses of such a compound.

ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF

The present invention relates to alkaloid aminoester derivatives acting as muscarinic receptor antagonists, processes for their preparation, compositions comprising them and therapeutic uses thereof.

ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF

The present invention relates to alkaloid aminoester derivatives acting as muscarinic receptor antagonists, processes for their preparation, compositions comprising them and therapeutic uses thereof.

Palladium-catalyzed coupling reaction of amino acids (esters) with aryl bromides and chlorides

The bulky and electron-rich MOP type ligands and Pd(dba)2 combinations showed high efficiency for the coupling reactions of amino acids and inactive aryl halides to give N-aryl amino acids. Under the catalytic conditions, not only α-amino acids, but also β-, γ-, and δ-amino acids have been coupled with aryl chlorides in moderate to high yields; in the case of optically pure β-amino acids as substrates, the optical purities of the coupling products retained.